Athos Therapeutics Inc
Athos Therapeutics is a biotechnology company focused on developing precision therapeutics for autoimmune diseases and chronic inflammatory conditions. They utilize artificial intelligence and machine learning to discover and develop novel drug candidates, targeting specific patient needs. Their primary customers include patients and healthcare providers seeking innovative treatment options. The company operates in the biotechnology and pharmaceutical sectors, emphasizing research and development.
Headcount
Website visitors
Workforce
Headcount by location
- United States100%
Split by department
- Engineering & R&D38%
- Consulting & Advisory15%
- Founder, Owner & Executive15%
- Operations7.7%
- Healthcare3.8%
Seniority distribution
- Less than 5 years48%
- 5 to 10 years26%
- 10 to 20 years19%
- 30 years and more7.4%
Funding
Raised to date
- 17 Apr 2026Debt$10.3M—
- 22 Jan 2024Undefined Funding$7.6M—
One earlier round, with its terms and sources.
Portfolio
Countries
- United States100%
Deal stage
- Series B100%
Deal size
- 3-10100%
Company size
- 11-50100%
Revenue
EBITDA
Revenue source: Modeled estimate
Recent news
- Athos Therapeutics Highlights Potential of AI-Generated, First-in-Class, ATH-063 for Inflammatory Bowel Disease in a Featured Discussionattends event
- Dimitrios Iliopoulos, CEO of AthosOmics.AI, to Speak at The Montgomery Summit on AI-Driven Drug Discoveryattends event
- Scientific Recognition at Crohn's & Colitis Congress 2026receives award
- A Co-Founder of Athos Therapeutics, Dr. Michael E. Jung, Wins the National Academy of Sciences Award for Chemistry in Service to Societyreceives award
Portfolio companies
Every holding by name, with what was paid, when, and how each one has grown since
People
How the team has changed month by month — joiners, leavers and where the hiring is going
Connections
Who at your firm already knows someone here, and how warm the path is
The full Athos Therapeutics Inc profile lives in Inven.
Your competitors are already on Inven
See how Inven turns hours of manual research into a single, structured workflow.